Additional file 2 of Rictor mediates p53 deactivation to facilitate the malignant transformation of hepatocytes and promote hepatocarcinogenesis

Additional file 2: Supplementary tables. Table S1. Oligonucleotides used for cloning Rictor 3’UTR to pMIR-REPORT. Table S2. Primer sequences for PCR. Table S3. The information about antibodies used in the study. Table S4. Summary of the data which were extracted from the total 376* HCC cases for bioinformatic analysis. Table S5. Total 114 out of 724 miRNAs which were consistently and positively expressed in all 3 cases of normal primary human hepatocytes (PHHCs) based on our microarray data (GEO accession number, GSE20077). Table S6. Clinical characteristics of the HCC patients from TCGA database. Table S7. Univariate analysis and multivariate analysis of the correlation of Rictor expression with overall survival (OS) among HCC patients. Table S8. Rictor expression associated with clinical pathological characteristics (logistic regression). Table S9. The details of GSEA comparing the low and high Rictor expression data sets. Table S10. Primers used for Sanger sequencing. Table S11. The functional annotation of miR-192 based on reported articles.